...
首页> 外文期刊>FEBS letters. >Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
【24h】

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

机译:MicroRNA-93是PTEN / Akt信号通路的新调节剂,参与卵巢癌细胞化疗药物顺铂化学敏感性的调节

获取原文
获取原文并翻译 | 示例
           

摘要

The mechanisms underlying ovarian cancer cell resistance to cisplatin (CDDP) are not fully understood. MicroRNAs (miRNAs) play important roles in tumorigenesis and drug resistance. In this paper, we utilized microRNA array and real-time PCR to show that miR-93 is significantly up-regulated in cisplatin-resistant ovarian cancer cells. In vitro assays show that over-expression and knock-down of miR-93 regulate apoptotic activity, and thereby cisplatin chemosensitivity, in ovarian cells. Furthermore, we found that miR-93 can directly target PTEN, and participates in the regulation of the AKT signaling pathway. MiR-93 inversely correlates with PTEN expression in CDDP-resistant and sensitive human ovarian cancer tissues. These results may have implications for therapeutic strategies aiming to overcome ovarian cancer cell resistance to cisplatin.
机译:卵巢癌细胞对顺铂(CDDP)耐药的潜在机制尚未完全了解。微小RNA(miRNA)在肿瘤发生和耐药性中起重要作用。在本文中,我们利用microRNA阵列和实时PCR来显示miR-93在顺铂耐药性卵巢癌细胞中显着上调。体外测定显示,miR-93的过度表达和敲低调节卵巢细胞的凋亡活性,从而调节顺铂的化学敏感性。此外,我们发现miR-93可以直接靶向PTEN,并参与AKT信号通路的调节。 MiR-93与抗CDDP的敏感人类卵巢癌组织中的PTEN表达呈负相关。这些结果可能对旨在克服卵巢癌细胞对顺铂耐药性的治疗策略有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号